Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00755456
Recruitment Status : Unknown
Verified March 2013 by Iperboreal Pharma Srl.
Recruitment status was:  Recruiting
First Posted : September 19, 2008
Last Update Posted : March 26, 2013
Information provided by (Responsible Party):
Iperboreal Pharma Srl

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2013
  Estimated Study Completion Date : December 2013